Color Health unveils AI-powered language expert to enhance cancer care decision-making

More than half of cancer centers see AI as answer to operational challenges, report shows

LeanTaaS Inc. has conducted a national survey of nearly 200 nursing and operational leaders from community hospitals, academic medical centers, and private oncology practices.

July 03, 2025

Vol.51 No.26

Clinical Trials & Tribulations

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers.

June 27, 2025

Vol.51 No.25

By Ghulam Rasool, Brian D. Gonzalez and Katherine Chung-Bridges

Clinical Roundup

City of Hope launches AI tool to reduce burden of cancer care

City of Hope is using generative artificial intelligence to create operational efficiency, enable AI-driven patient personalization, improve access to clinical trials, and empower breakthrough research.

June 27, 2025

Vol.51 No.25

Drugs & Targets

SU2C, SandboxAQ collaborate to accelerate treatment innovation

Stand Up To Cancer and SandboxAQ announced a collaboration that brings SandboxAQ’s Large Quantitative Models to SU2C-funded cancer research projects.

June 13, 2025

Vol.51 No.23

Cancer Policy

FDA rolls out agency-wide AI tool

FDA rolled out a generative artificial intelligence tool designed to help employees across the agency “work more efficiently.”

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Color Health unveils AI-powered language expert to enhance cancer care decision-making

YOU MAY BE INTERESTED IN

More than half of cancer centers see AI as answer to operational challenges, report shows

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

City of Hope launches AI tool to reduce burden of cancer care

SU2C, SandboxAQ collaborate to accelerate treatment innovation

FDA rolls out agency-wide AI tool

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Renew today!

Subscriber content

Never miss an issue!

Login